Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Shixian Pharmaceutical is a Chinese pharmaceutical company based in Jilin Province that focuses on the development, production, and sale of finished drug products and active pharmaceutical ingredients (APIs). The company operates manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to produce a variety of formulations, including tablets, capsules, and injections. Its product portfolio spans several therapeutic areas such as gastrointestinal health, cardiovascular medicine, and anti-infectives. Jilin Shixian Pharmaceutical serves both domestic and international markets, leveraging its regional manufacturing base to provide essential medicines. The company is part of the broader industrial landscape in Jilin, contributing to the province's healthcare and chemical sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Shixian Pharmaceutical.